A Risk Model for Patients with PSA-Only Recurrence (Biochemical Recurrence) Based on PSA and PSMA PET/CT: An Individual Patient Data Meta-Analysis

A Risk Model for Patients with PSA-Only Recurrence (Biochemical Recurrence) Based on PSA and PSMA PET/CT: An Individual Patient Data Meta-Analysis

An individual patient meta-analysis followed 1216 patients with PSA-only recurrence (biochemical recurrence, BCR) restaged with [<sup>68</sup>Ga]Ga-PSMA-11 PET/CT before the salvage treatment for median 3.5 years and analyzed the overall survival (OS). A new risk model included a good ri...

Full description

Bibliographic Details
Main Authors: Rie von Eyben, Daniel S. Kapp, Manuela Andrea Hoffmann, Cigdem Soydal, Christian Uprimny, Irene Virgolini, Murat Tuncel, Mathieu Gauthé, Finn E. von Eyben
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Cancers
Subjects:
biochemical recurrence
new generation imaging
overall survival
prognostic factors
prostate cancer
restaging
Online Access:https://www.mdpi.com/2072-6694/14/21/5461

Internet

https://www.mdpi.com/2072-6694/14/21/5461

Similar Items